Suppr超能文献

骨洪注射液治疗缺血性脑卒中的化学成分、药理学及药代动力学研究

Chemical composition, pharmacology and pharmacokinetic studies of GuHong injection in the treatment of ischemic stroke.

作者信息

Wang Qiuyue, Yang Zhihua, Guo Liuli, Li Zhenzhen, Liu Yangxi, Feng Shaoling, Wang Yanxia

机构信息

Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

出版信息

Front Pharmacol. 2023 Sep 7;14:1261326. doi: 10.3389/fphar.2023.1261326. eCollection 2023.

Abstract

GuHong injection is composed of safflower and -acetyl-L-glutamine. It is widely used in clinical for cerebrovascular diseases, such as ischemic stroke and related diseases. The objective of this review is to comprehensively summarize the most recent information related to GuHong in the treatment of stroke, including chemical composition, clinical studies, potential pharmacological mechanisms and pharmacokinetics. Additionally, it examines possible scientific gaps in current study and aims to provide a reliable reference for future GuHong studies. The systematic review reveals that the chemical composition of safflower in GuHong is more than 300 chemical components in five categories. GuHong injection is primarily used in clinical applications for acute ischemic stroke and related diseases. Pharmacological investigations have indicated that GuHong acts in the early and recovery stages of ischemic stroke by anti-inflammatory, anti-oxidative stress, anti-coagulation, neuroprotective and anti-apoptotic mechanisms simultaneously. Pharmacokinetic studies found that the main exposed substances in rat plasma after GuHong administration are hydroxysafflor yellow A and -acetyl-L-glutamine, and -acetyl-L-glutamine could exert its pharmacological effect across the blood-brain barrier. As a combination of Chinese herb and chemical drug, GuHong injection has great value in drug research and clinical treatment, especially for ischemic stroke disease. This article represents a comprehensive and systematic review of existing studies on GuHong injection, including chemical composition, pharmacological mechanism, and pharmacokinetics, which provides reference significance for the clinical treatment of ischemic stroke with GuHong, as well as provides guidance for further study.

摘要

谷红注射液由红花和乙酰半胱氨酸组成。它在临床上广泛用于治疗脑血管疾病,如缺血性中风及相关疾病。本综述的目的是全面总结谷红在治疗中风方面的最新信息,包括化学成分、临床研究、潜在药理机制和药代动力学。此外,它还审视了当前研究中可能存在的科学空白,旨在为未来谷红的研究提供可靠的参考。系统评价显示,谷红中红花的化学成分有五大类300多种化学成分。谷红注射液主要用于急性缺血性中风及相关疾病的临床应用。药理研究表明,谷红在缺血性中风的早期和恢复期通过抗炎、抗氧化应激、抗凝、神经保护和抗凋亡机制发挥作用。药代动力学研究发现,谷红给药后大鼠血浆中的主要暴露物质是羟基红花黄色素A和乙酰半胱氨酸,且乙酰半胱氨酸可透过血脑屏障发挥其药理作用。作为中药与化学药物的组合,谷红注射液在药物研究和临床治疗中具有重要价值,尤其是对缺血性中风疾病。本文对谷红注射液现有研究进行了全面系统的综述,包括化学成分、药理机制和药代动力学,为谷红治疗缺血性中风的临床应用提供参考意义,也为进一步研究提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef57/10512552/96751f4a0632/fphar-14-1261326-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验